Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011

Emerging Infectious Diseases

Volumn 21, Issue 1, 2015, Pages 107-110

  Wilking, Hendrik ^a   Fingerle, Volker ^b   Klier, Christiane ^b   Thamm, Michael ^a   Stark, Klaus ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b German National Reference Centre for Borrelia   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY;

ADULT; AGED; ARTICLE; BLOTTING; BORRELIA BURGDORFERI; CROSS-SECTIONAL STUDY; EDUCATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INFECTION RISK; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; QUESTIONNAIRE; RISK FACTOR; RURAL AREA; SEROPREVALENCE; ADOLESCENT; AGE DISTRIBUTION; BLOOD; CHILD; GERMANY; IMMUNOLOGY; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PREVALENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; LYME DISEASE; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84919594925     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2101.140009     Document Type: Article

References (15)

1. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, Leonhard S, Hofmann H, Weber K, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279-90. http://dx.doi. org/10.1016/j.ijmm.2007.05.002
2. Strle F, Stanek G. Clinical manifestations and diagnosis of Lyme borreliosis. Curr Probl Dermatol. 2009;37:51-110.
3. Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 2011;16:pii:19906.
4. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease- United States, 1992-2006. MMWR Surveill Summ. 2008;57:1-9.
5. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-24. http://dx.doi. org/10.1056/NEJM199511163332004
6. Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis. 1999;18:697-703. http://dx.doi. org/10.1007/s100960050381
7. Wilking H, Stark K. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. Ticks Tick Borne Dis. 2014;5:219-24. http://dx.doi.org/10.1016/j. ttbdis.2013.10.010
8. Ertel SH, Nelson RS, Cartter ML. Effect of surveillance method on reported characteristics of Lyme disease, Connecticut, 1996-2007. Emerg Infect Dis. 2012;18:242-7. http://dx.doi.org/10.3201/ eid1802.101219
9. Dehnert M, Fingerle V, Klier C, Talaska T, Schlaud M, Krause G, et al. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in children and adolescents in Germany (KiGGS). PLoS ONE. 2012;7:e41321. http://dx.doi.org/10.1371/ journal.pone.0041321
10. Scheidt-Nave C, Kamtsiuris P, Gosswald A, Holling H, Lange M, Busch MA, et al. German health interview and examination survey for adults (DEGS)-design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730. http://dx.doi.org/10.1186/1471-2458-12-730
11. Tomao P, Ciceroni L, D'Ovidio MC, De RM, Vonesch N, Iavicoli S, et al. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy. Eur J Clin Microbiol Infect Dis. 2005;24:457-63. http://dx.doi.org/10.1007/ s10096-005-1348-0
12. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17:891-6. http://dx.doi.org/10.1023/A:1015600729900
13. Hassler D, Zoller L, Haude M, Hufnagel HD, Sonntag HG. Lyme borreliosis in an endemic region in Europe: prevalence of antibodies and clinical spectrum [in German]. Dtsch Med Wochenschr. 1992;117:767-74. http://dx.doi.org/10.1055/s-2008-1062374
14. Carlsson SA, Granlund H, Nyman D, Wahlberg P. IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland. Scand J Infect Dis. 1998;30:501-3. http://dx.doi. org/10.1080/00365549850161520
15. Nadelman RB, Hanincova K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med. 2012;367:1883-90. http://dx.doi.org/10.1056/NEJMoa1114362